Symphony DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
4.19×2.39×0.76×0.82×0.76×
−0.23×−0.57×0.97×1.27×1.36×
12.1%9.2%18.3%12.3%9.4%
0.96×0.96×1.24×0.88×0.86×
1.76×1.89×1.75×1.63×1.59×
−19.3%−22.6%29.4%18.3%13.4%
−21.6%−21.6%28.1%18.2%13.6%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SYMPHONY₹511.60

Symphony Limited

· Consumer Goods
₹ CrorePeersORIENTELECBOSCH-HCILCARYSILAMBERCROMPTONSTOVEKRAFTPGELWHIRLPOOLMcap ₹3,512 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.760.820.762.394.19
Interest Burden (Pretax/EBIT) ×1.361.270.97-0.57-0.23
EBIT Margin %9.4312.2818.349.2012.05
Asset Turnover ×0.860.881.240.960.96
Financial Leverage (Assets/Equity) ×1.591.631.751.891.76
ROE (5-step product, year-end total equity) %13.3818.3229.38-22.60-19.35
ROE (owners' profit / average owners' equity) %13.6018.1628.08-21.59-21.59
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.